Clinical Trial Update: Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating idarubicin, cytarabine, and sorafenib in acute myeloid leukemia and related myeloid disorders; study completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Disorders

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Idarubicin (idarubicin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: AML, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-07-13